Ratings by Maxim Group (Jason McCarthy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Iterum Therapeutics | ITRM | Downgrade | Hold (Buy) |
0.15 (0.17) |
13.33% | Details | |
| 2/27/2026 | Polaryx Therapeutics | PLYX | New Coverage | Buy (N/A) |
3.19 (2.74) |
-14.11% | Details | |
| 2/11/2026 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | INVO Fertility | IVF | Upgrade | Buy (Hold) |
1.11 (0.85) |
-23.42% | Details | |
| 1/30/2026 | Quince Therapeutics Inc. | QNCX | Downgrade | Hold (Buy) |
0.27 (0.10) |
-62.96% | Details | |
| 1/23/2026 | Co-Diagnostics | CODX | Downgrade | Hold (Buy) |
2.36 (2.36) |
0% | Details | |
| 12/17/2025 | VistaGen Therapeutics | VTGN | Downgrade | Hold (Buy) |
4.36 (0.61) |
-86.01% | Details | |
| 11/26/2025 | Co-Diagnostics | CODX | New Coverage | Buy (N/A) |
0.33 (2.36) |
615.15% | Details | |
| 11/19/2025 | Artelo Biosciences, Inc. | ARTL | Downgrade | Hold (Buy) |
1.89 (1.14) |
-39.68% | Details | |
| 11/11/2025 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Cero Therapeutics | CERO | Downgrade | Hold (Buy) |
0.10 (0.10) |
0% | Details | |
| 10/21/2025 | ABPRO Technologies Corp. | ABP | Downgrade | Hold (Buy) |
0.22 (0.52) |
136.36% | Details | |
| 10/7/2025 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2025 | Vyome Holdings | HIND | New Coverage | Buy (N/A) |
0.00 (2.80) |
0% | Details | |
| 9/30/2025 | Adial Pharmaceuticals Inc | ADIL | Upgrade | Buy (Hold) |
0.33 (1.83) |
454.55% | Details | |
| 9/24/2025 | Azitra, Inc. | AZTR | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2025 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2025 | CNS Pharmasceuticals Inc. | CNSP | Upgrade | Buy (Hold) |
7.52 (2.94) |
-60.9% | Details | |
| 9/10/2025 | Neuphoria Therapeutics Inc. | NEUP | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2025 | AIM ImmunoTech | AIM | New Coverage | Buy (N/A) |
2.44 (0.69) |
-71.72% | Details | |
| 9/4/2025 | Coherus Biosciences | CHRS | Upgrade | Buy (Hold) |
1.26 (1.82) |
44.44% | Details | |
| 8/18/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2025 | Brainstorm Cell Therapeutics | BCLI | Downgrade | Hold (Buy) |
1.17 (1.17) |
0% | Details | |
| 7/18/2025 | Akari Therapeutics | AKTX | New Coverage | Buy (N/A) |
1.13 (0.25) |
-77.88% | Details | |
| 7/15/2025 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2025 | INmune Bio Inc. | INMB | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Citius Pharmaceuticals | CTXR | Downgrade | Hold (Buy) |
0.72 (0.84) |
16.67% | Details | |
| 5/20/2025 | Bionano Genomics | BNGO | Upgrade | Buy (Hold) |
3.74 (1.12) |
-70.05% | Details | |
| 5/19/2025 | Cero Therapeutics | CERO | New Coverage | Buy (N/A) |
0.59 (0.10) |
-83.05% | Details | |
| 5/14/2025 | Cellectar Biosciences | CLRB | Downgrade | Hold (Buy) |
0.24 (2.76) |
1050% | Details | |
| 5/12/2025 | ProMIS Neurosciences | PMN | New Coverage | Buy (N/A) |
0.50 (23.40) |
4580% | Details | |
| 5/8/2025 | Theriva Biologics | TOVX | Downgrade | Hold (Buy) |
0.81 (0.18) |
-77.78% | Details | |
| 5/8/2025 | Medicus Pharma Ltd. | MDCX | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | NAYA Bioscience Inc. | NAYA | Downgrade | Hold (Buy) |
1.80 (2.20) |
22.22% | Details | |
| 4/4/2025 | Galmed Pharmaceuticals | GLMD | Downgrade | Hold (Buy) |
1.46 (0.66) |
-54.79% | Details | |
| 3/27/2025 | Kairos Pharma | KAPA | New Coverage | Buy (N/A) |
0.96 (0.63) |
-34.38% | Details | |
| 3/25/2025 | CNS Pharmasceuticals Inc. | CNSP | Downgrade | Hold (Buy) |
3.38 (7.52) |
122.49% | Details | |
| 3/25/2025 | Annovis Bio Inc. | ANVS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Moleculin Biotech | MBRX | Upgrade | Buy (Hold) |
1.06 (2.08) |
96.23% | Details | |
| 3/21/2025 | Anixa Biosciences | ANIX | New Coverage | Buy (N/A) |
3.15 (2.85) |
-9.52% | Details | |
| 3/13/2025 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | Azitra, Inc. | AZTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2025 | ABPRO Technologies Corp. | ABP | New Coverage | Buy (N/A) |
0.84 (0.52) |
-38.1% | Details | |
| 2/13/2025 | INmune Bio Inc. | INMB | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Moleculin Biotech | MBRX | Downgrade | Hold (Buy) |
0.51 (2.08) |
307.84% | Details | |
| 1/23/2025 | NAYA Bioscience Inc. | NAYA | Upgrade | Buy (Hold) |
0.46 (2.20) |
378.26% | Details | |
| 1/10/2025 | Reviva Pharmaceuticals | RVPH | Upgrade | Buy (Hold) |
1.87 (0.18) |
-90.37% | Details | |
| 1/7/2025 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2024 | Medicus Pharma Ltd. | MDCX | New Coverage | Buy (N/A) |
2.95 (0.39) |
-86.78% | Details | |
| 12/12/2024 | Alterity Therapeutics | ATHE | New Coverage | Buy (N/A) |
2.27 (3.43) |
51.1% | Details | |
| 11/26/2024 | OS Therapies, Inc | OSTX | New Coverage | Buy (N/A) |
2.05 (1.57) |
-23.41% | Details | |
| 11/15/2024 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Theriva Biologics | TOVX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Indaptus Therapeutics | INDP | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2024 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Quince Therapeutics Inc. | QNCX | New Coverage | Buy (N/A) |
1.46 (0.27) |
-81.51% | Details | |
| 11/5/2024 | TuHURA Biosciences | HURA | New Coverage | Buy (N/A) |
5.48 (1.50) |
-72.63% | Details | |
| 11/1/2024 | Compass Pathways | CMPS | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Matinas BioPharma Holdings Inc. | MTNB | Downgrade | Hold (Buy) |
1.93 (0.60) |
-68.91% | Details | |
| 10/30/2024 | Brainstorm Cell Therapeutics | BCLI | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Annovis Bio Inc. | ANVS | Maintain | Buy (Hold) |
|
Details | ||
| 10/22/2024 | AIM ImmunoTech | AIM | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Mesoblast Limited | MESO | Upgrade | Buy (Hold) |
6.74 (15.85) |
135.16% | Details | |
| 9/10/2024 | CNS Pharmasceuticals Inc. | CNSP | Upgrade | Buy (Hold) |
0.14 (2.94) |
2000% | Details | |
| 9/9/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Cyclo Therapeutics | CYTH | Downgrade | Hold (Buy) |
0.83 (0.72) |
-13.25% | Details | |
| 8/16/2024 | Reviva Pharmaceuticals | RVPH | Downgrade | Hold (Buy) |
0.69 (0.18) |
-73.91% | Details | |
| 8/9/2024 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2024 | Synaptogenix, Inc. | SNPX | New Coverage | Buy (N/A) |
4.29 (7.85) |
82.98% | Details | |
| 7/11/2024 | Brainstorm Cell Therapeutics | BCLI | Upgrade | Buy (Hold) |
0.35 (1.17) |
234.29% | Details | |
| 6/20/2024 | Virios Therapeutics | VIRI | New Coverage | Buy (N/A) |
0.25 (0.16) |
-36% | Details | |
| 6/7/2024 | Avenue Therapeutics | ATXI | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | CareDx, Inc | APDN | Downgrade | Hold (Buy) |
14.83 (5.62) |
-62.1% | Details | |
| 5/8/2024 | Neurobo Pharmaceuticals | NRBO | New Coverage | Buy (N/A) |
3.84 (2.36) |
-38.54% | Details | |
| 5/6/2024 | Talphera | TLPH | New Coverage | Buy (N/A) |
1.02 (0.87) |
-14.71% | Details | |
| 4/30/2024 | Annovis Bio Inc. | ANVS | Downgrade | Hold (Buy) |
7.28 (2.49) |
-65.8% | Details | |
| 4/9/2024 | Lipella Pharmaceuticals Inc. | LIPO | New Coverage | Buy (N/A) |
0.70 (2.36) |
237.14% | Details | |
| 4/9/2024 | Rezolute | RZLT | New Coverage | Buy (N/A) |
2.53 (3.11) |
22.92% | Details | |
| 4/3/2024 | atai Life Sciences N.V | ATAI | Upgrade | Buy (Hold) |
1.87 (3.39) |
81.28% | Details | |
| 4/2/2024 | Genelux Corp. | GNLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | RenovoRx Inc. | RNXT | Upgrade | Buy (Hold) |
1.60 (0.79) |
-50.63% | Details | |
| 2/29/2024 | Azitra, Inc. | AZTR | New Coverage | Buy (N/A) |
0.26 (0.18) |
-30.77% | Details | |
| 12/26/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Hold (Buy) |
317.85 (329.83) |
3.77% | Details | |
| 12/22/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Hold (Buy) |
215.19 (329.83) |
53.27% | Details | |
| 12/14/2023 | Belite Bio, Inc, ADR | BLTE | New Coverage | Buy (N/A) |
44.20 (173.30) |
292.08% | Details | |
| 12/11/2023 | Avenue Therapeutics | ATXI | New Coverage | Buy (N/A) |
0.15 (0.42) |
180% | Details | |
| 11/15/2023 | RenovoRx Inc. | RNXT | Downgrade | Hold (Buy) |
0.75 (0.79) |
5.33% | Details | |
| 11/13/2023 | Bionano Genomics | BNGO | Downgrade | Hold (Buy) |
1.30 (1.12) |
-13.85% | Details | |
| 11/8/2023 | Coherus Biosciences | CHRS | Downgrade | Hold (Buy) |
2.47 (1.26) |
-48.99% | Details | |
| 11/6/2023 | Indaptus Therapeutics | INDP | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | Kintara Therapeutics, Inc | KTRA | Downgrade | Hold (Buy) |
3.76 (0.22) |
-94.15% | Details | |
| 10/18/2023 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | Acurx Pharmaceuticals inc. | ACXP | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2023 | Bionomics Ltd. | BNOX | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2023 | Brainstorm Cell Therapeutics | BCLI | Downgrade | Hold (Buy) |
0.39 (1.17) |
200% | Details | |
| 9/27/2023 | Cyclo Therapeutics | CYTH | Upgrade | Buy (Hold) |
1.46 (0.72) |
-50.68% | Details | |
| 9/14/2023 | NLS Pharmaceutics | NLSP | Downgrade | Hold (Buy) |
0.82 (0.76) |
-7.32% | Details | |
| 9/13/2023 | Blue Water Vaccines Inc. | BWV | Downgrade | Hold (Buy) |
0.68 (0.18) |
-73.53% | Details | |
| 9/12/2023 | Gain Therapeutics | GANX | New Coverage | Buy (N/A) |
3.66 (3.05) |
-16.67% | Details | |
| 9/12/2023 | Genelux Corp. | GNLX | New Coverage | Buy (N/A) |
22.40 (2.71) |
-87.9% | Details | |
| 9/11/2023 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
0.90 (3.12) |
246.67% | Details | |
| 8/16/2023 | INVO Bioscience Inc. | INVO | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Theriva Biologics | TOVX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Mesoblast Limited | MESO | Downgrade | Hold (Buy) |
1.64 (15.85) |
866.46% | Details | |
| 8/4/2023 | Mesoblast Limited | MESO | Downgrade | Hold (Buy) |
3.99 (15.85) |
297.24% | Details | |
| 7/24/2023 | Galmed Pharmaceuticals | GLMD | Upgrade | Buy (Hold) |
1.15 (0.66) |
-42.61% | Details | |
| 7/14/2023 | Kintara Therapeutics, Inc | KTRA | Upgrade | Buy (Hold) |
4.60 (0.22) |
-95.22% | Details | |
| 6/16/2023 | Bionomics Ltd. | BNOX | New Coverage | Buy (N/A) |
2.44 (0.25) |
-89.75% | Details | |
| 6/5/2023 | Oncolytics Biotech | ONCY | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2023 | Biocept | BIOC | Downgrade | Hold (Buy) |
0.34 (0.43) |
26.47% | Details | |
| 4/13/2023 | ContraFect Corp. | CFRX | Upgrade | Buy (Hold) |
1.01 (0.23) |
-77.23% | Details | |
| 4/3/2023 | NightHawk Radiology | NHWK | Downgrade | Hold (Buy) |
0.87 (0.41) |
-52.87% | Details | |
| 3/29/2023 | Monopar Therapeutics | MNPR | Downgrade | Hold (Buy) |
1.45 (57.61) |
3873.1% | Details | |
| 3/20/2023 | Cyclo Therapeutics | CYTH | Downgrade | Hold (Buy) |
1.11 (0.72) |
-35.14% | Details | |
| 3/20/2023 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Indaptus Therapeutics | INDP | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Panbella Therapeutics | PBLA | Upgrade | Buy (Hold) |
0.51 (0.01) |
-98.04% | Details | |
| 3/17/2023 | Zevra Therapeutics, Inc. | ZVRA | New Coverage | Buy (N/A) |
4.71 (8.98) |
90.66% | Details | |
| 1/10/2023 | Amryt | AMYT | Downgrade | Hold (Buy) |
14.51 (14.70) |
1.31% | Details | |
| 1/6/2023 | atai Life Sciences N.V | ATAI | Downgrade | Hold (Buy) |
2.63 (3.39) |
28.9% | Details | |
| 12/19/2022 | Synaptogenix, Inc. | SNPX | Downgrade | Hold (Buy) |
1.20 (7.85) |
554.17% | Details | |
| 12/8/2022 | Blue Water Vaccines Inc. | BWV | New Coverage | Buy (N/A) |
1.15 (0.18) |
-84.35% | Details | |
| 12/8/2022 | NLS Pharmaceutics | NLSP | Upgrade | Buy (Hold) |
0.88 (0.76) |
-13.64% | Details | |
| 11/16/2022 | Cyclo Therapeutics | CYTH | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | ABVC BioPharma, Inc. | ABVC | Downgrade | Hold (Buy) |
0.72 (1.34) |
86.11% | Details | |
| 11/15/2022 | Brainstorm Cell Therapeutics | BCLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | MindMed | MNMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | GeoVax Labs Inc. | GOVX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Inovio Pharmaceuticals | INO | Downgrade | Hold (Buy) |
2.14 (1.74) |
-18.69% | Details | |
| 11/8/2022 | Cellectar Biosciences | CLRB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | NLS Pharmaceutics | NLSP | Downgrade | Hold (Buy) |
0.59 (0.76) |
28.81% | Details | |
| 11/1/2022 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2022 | Panbella Therapeutics | PBLA | Downgrade | Hold (Buy) |
0.23 (0.01) |
-95.65% | Details | |
| 10/12/2022 | Brooklyn ImmunoTherapeutics Inc. | BTX | Downgrade | Hold (Buy) |
0.21 (6.42) |
2957.14% | Details | |
| 9/29/2022 | Kintara Therapeutics, Inc | KTRA | Downgrade | Hold (Buy) |
0.11 (0.22) |
100% | Details | |
| 8/23/2022 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | CNS Pharmasceuticals Inc. | CNSP | Downgrade | Hold (Buy) |
0.24 (2.94) |
1125% | Details | |
| 8/17/2022 | Adial Pharmaceuticals Inc | ADIL | Downgrade | Hold (Buy) |
0.57 (0.33) |
-42.11% | Details | |
| 8/16/2022 | Aridis Pharmaceuticals | ARDS | Downgrade | Hold (Buy) |
2.19 (0.00) |
-100% | Details | |
| 8/16/2022 | MindMed | MNMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Synthetic Biologics | SYN | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Artelo Biosciences, Inc. | ARTL | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Galmed Pharmaceuticals | GLMD | Downgrade | Hold (Buy) |
0.44 (0.66) |
50% | Details | |
| 7/14/2022 | ContraFect Corp. | CFRX | Downgrade | Hold (Buy) |
2.85 (0.23) |
-91.93% | Details | |
| 6/17/2022 | Femasys Inc. | FEMY | New Coverage | Buy (N/A) |
1.30 (0.53) |
-59.23% | Details | |
| 6/17/2022 | ABVC BioPharma, Inc. | ABVC | New Coverage | Buy (N/A) |
0.96 (1.34) |
39.58% | Details | |
| 6/15/2022 | Biocept | BIOC | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2022 | Vertex | VRTX | Upgrade | Buy (Hold) |
268.65 (456.69) |
69.99% | Details | |
| 5/26/2022 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.38 (4.61) |
1113.16% | Details | |
| 5/12/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2022 | Synaptogenix, Inc. | SNPX | New Coverage | Buy (N/A) |
7.03 (7.85) |
11.66% | Details | |
| 3/16/2022 | Unicycive Therapeutics | UNCY | New Coverage | Buy (N/A) |
1.07 (6.59) |
515.89% | Details | |
| 1/19/2022 | INVO Bioscience Inc. | INVO | New Coverage | Buy (N/A) |
3.69 (0.83) |
-77.51% | Details | |
| 11/30/2021 | Citius Pharmaceuticals | CTXR | New Coverage | Buy (N/A) |
1.62 (0.84) |
-48.15% | Details | |
| 11/30/2021 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
10.98 (3.39) |
-69.13% | Details | |
| 11/29/2021 | Acurx Pharmaceuticals inc. | ACXP | New Coverage | Buy (N/A) |
4.89 (1.35) |
-72.39% | Details | |
| 11/19/2021 | Cybin Inc. | CYBN | Downgrade | Hold (Buy) |
1.64 (8.28) |
404.88% | Details | |
| 11/15/2021 | Appili Therapeutics Inc. | APLI | Downgrade | Hold (Buy) |
0.00 (0.00) |
0% | Details | |
| 10/29/2021 | Protagenic Therapeutics, Inc | PTIX | New Coverage | Buy (N/A) |
1.80 (0.74) |
-58.89% | Details | |
| 10/19/2021 | Indaptus Therapeutics | INDP | Upgrade | Buy (Hold) |
7.54 (1.85) |
-75.46% | Details | |
| 10/6/2021 | BioTime, Inc. | BTX | New Coverage | Buy (N/A) |
9.01 (0.21) |
-97.67% | Details | |
| 10/6/2021 | RenovoRx Inc. | RNXT | New Coverage | (N/A) |
5.72 (0.79) |
-86.19% | Details | |
| 10/4/2021 | GeoVax Labs Inc. | GOVX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Omeros Corp. | OMER | Downgrade | Hold (Buy) |
8.54 (11.54) |
35.13% | Details | |
| 10/1/2021 | Omeros Corp. | OMER | Downgrade | Hold (Buy) |
13.79 (11.54) |
-16.32% | Details | |
| 8/11/2021 | CohBar | CWBR | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Reviva Pharmaceuticals | RVPH | New Coverage | Buy (N/A) |
3.83 (0.18) |
-95.3% | Details | |
| 7/1/2021 | Stealth BioTherapeutics | MITO | New Coverage | Buy (N/A) |
1.56 (0.32) |
-79.49% | Details | |
| 6/29/2021 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
2.17 (1.95) |
-10.14% | Details | |
| 6/28/2021 | Compass Pathways | CMPS | New Coverage | Buy (N/A) |
33.49 (6.58) |
-80.35% | Details | |
| 6/28/2021 | MindMed | MNMD | New Coverage | Buy (N/A) |
55.80 (15.02) |
-73.08% | Details | |
| 6/24/2021 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2021 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | Clene, Inc. | CLNN | New Coverage | Buy (N/A) |
8.95 (5.36) |
-40.11% | Details | |
| 5/13/2021 | Galmed Pharmaceuticals | GLMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Avanos Medical | AVNS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2021 | BioLineRx | BLRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2021 | CohBar | CWBR | New Coverage | Buy (N/A) |
1.24 (0.41) |
-66.94% | Details | |
| 4/19/2021 | Fennec Pharmaceuticals Inc. | FENC | New Coverage | Buy (N/A) |
6.27 (7.70) |
22.81% | Details | |
| 4/7/2021 | Mesoblast Limited | MESO | Upgrade | Buy (Hold) |
8.45 (15.85) |
87.57% | Details | |
| 3/31/2021 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2021 | Amryt | AMYT | New Coverage | Buy (N/A) |
13.84 (14.70) |
6.21% | Details | |
| 3/29/2021 | Co-Diagnostics | CODX | Downgrade | Hold (Buy) |
9.70 (2.36) |
-75.67% | Details | |
| 3/25/2021 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Synthetic Biologics | SYN | Upgrade | Buy (Hold) |
0.92 (1.02) |
10.87% | Details | |
| 3/12/2021 | Synthetic Biologics | SYN | Upgrade | Buy (Hold) |
0.71 (1.02) |
43.66% | Details | |
| 3/12/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2021 | Entera Bio | ENTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2021 | Panbella Therapeutics | PBLA | New Coverage | Buy (N/A) |
4.17 (0.23) |
-94.48% | Details | |
| 3/10/2021 | MediciNova | MNOV | New Coverage | Buy (N/A) |
5.68 (1.36) |
-76.06% | Details | |
| 2/18/2021 | Titan Pharmaceuticals | TTNP | Upgrade | Buy (Hold) |
3.55 (4.61) |
29.86% | Details | |
| 2/17/2021 | Artelo Biosciences Inc | ARTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Cyclo Therapeutics | CYTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2021 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | Brainstorm Cell Therapeutics | BCLI | Upgrade | Buy (Hold) |
6.17 (1.17) |
-81.04% | Details | |
| 1/25/2021 | Kintara Therapeutics, Inc | KTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | INmune Bio Inc. | INMB | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2021 | Cellectar Biosciences | CLRB | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Cellectar Biosciences | CLRB | Maintain | Hold (N/A) |
|
Details | ||
| 1/7/2021 | Artelo Biosciences, Inc. | ARTL | Upgrade | Buy (Hold) |
0.89 (1.14) |
28.09% | Details | |
| 12/23/2020 | Soligenix | SNGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2020 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2020 | Mesoblast Limited | MESO | Downgrade | Hold (Buy) |
8.59 (8.45) |
-1.63% | Details | |
| 12/10/2020 | CNS Pharmasceuticals Inc. | CNSP | New Coverage | Buy (N/A) |
2.58 (2.94) |
13.95% | Details | |
| 12/9/2020 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
44.40 (4.97) |
-88.81% | Details | |
| 11/19/2020 | Galapagos NV | GLPG | New Coverage | Buy (N/A) |
123.95 (32.92) |
-73.44% | Details | |
| 11/16/2020 | Adamis Pharmaceuticals | ADMP | Downgrade | Hold (Buy) |
0.68 (0.78) |
14.71% | Details | |
| 11/6/2020 | BeiGene, Ltd. | BGNE | Downgrade | Hold (Buy) |
300.00 (184.71) |
-38.43% | Details | |
| 10/30/2020 | 9 Meter Biopharma | NMTR | New Coverage | (N/A) |
0.68 (0.07) |
-89.71% | Details | |
| 10/16/2020 | Plus Therapeutics Inc. | PSTV | New Coverage | Buy (N/A) |
2.56 (0.29) |
-88.67% | Details | |
| 10/5/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2020 | Synthetic Biologics | SYN | Downgrade | Hold (Buy) |
0.46 (0.71) |
54.35% | Details | |
| 10/2/2020 | Synthetic Biologics | SYN | Downgrade | Hold (Buy) |
0.46 (1.02) |
121.74% | Details | |
| 9/28/2020 | Inovio Pharmaceuticals | INO | Upgrade | Buy (Hold) |
16.94 (1.74) |
-89.73% | Details | |
| 9/15/2020 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
66.34 (143.93) |
116.96% | Details | |
| 9/14/2020 | Cassava Sciences | SAVA | Upgrade | Buy (Hold) |
3.32 (2.03) |
-38.86% | Details | |
| 8/24/2020 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
1.01 (1.00) |
-0.99% | Details | |
| 8/17/2020 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.28 (4.61) |
1546.43% | Details | |
| 8/14/2020 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.30 (4.61) |
1436.67% | Details | |
| 7/30/2020 | Onconova Therapeutics | ONTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | TFF Pharmaceuticals | TFFP | New Coverage | Buy (N/A) |
6.22 (0.07) |
-98.87% | Details | |
| 7/8/2020 | DiaMedica Therapeutics Inc. | DMAC | New Coverage | Buy (N/A) |
6.75 (7.71) |
14.22% | Details | |
| 7/1/2020 | Inovio Pharmaceuticals | INO | Downgrade | Hold (Buy) |
26.95 (16.94) |
-37.14% | Details | |
| 6/23/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2020 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2020 | Precipio | PRPO | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2020 | Co-Diagnostics | CODX | Upgrade | Buy (Hold) |
18.85 (2.36) |
-87.48% | Details | |
| 5/15/2020 | Cassava Sciences | SAVA | Downgrade | Hold (Buy) |
8.11 (3.32) |
-59.06% | Details | |
| 5/15/2020 | Onconova Therapeutics | ONTX | Upgrade | Buy (Hold) |
0.36 (1.01) |
180.56% | Details | |
| 5/13/2020 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Adamis Pharmaceuticals | ADMP | Upgrade | Buy (Hold) |
0.52 (0.68) |
30.77% | Details | |
| 5/12/2020 | Appolo Therapeutics | APLI | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2020 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | Immutep Limited | IMMP | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | AIM ImmunoTech | AIM | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Appili Therapeutics Inc. | APLI | New Coverage | Buy (N/A) |
0.00 (0.00) |
0% | Details | |
| 3/10/2020 | Cidara Therapeutics | CDTX | New Coverage | Buy (N/A) |
2.65 (221.38) |
8253.96% | Details | |
| 3/6/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Co-Diagnostics | CODX | Downgrade | Hold (Buy) |
17.81 (2.36) |
-86.75% | Details | |
| 2/24/2020 | ContraFect Corp. | CFRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | Aptose Biosciences | APTO | New Coverage | Buy (N/A) |
8.60 (1.71) |
-80.12% | Details | |
| 2/18/2020 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Navidea Biopharmaceuticals | NAVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Heat Biologics | HTBX | New Coverage | Buy (N/A) |
0.26 (2.83) |
988.46% | Details | |
| 2/3/2020 | Capricor Therapeutics | CAPR | Upgrade | Buy (Hold) |
1.53 (27.90) |
1723.53% | Details | |
| 1/8/2020 | Xenetic Biosciences | XBIO | New Coverage | Buy (N/A) |
1.47 (2.29) |
55.78% | Details | |
| 12/18/2019 | Atossa Genetics | ATOS | Upgrade | Buy (Hold) |
1.42 (4.53) |
219.01% | Details | |
| 11/26/2019 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
0.14 (0.36) |
157.14% | Details | |
| 11/25/2019 | Adamis Pharmaceuticals | ADMP | Downgrade | Hold (Buy) |
1.26 (0.78) |
-38.1% | Details | |
| 11/22/2019 | Precipio | PRPO | New Coverage | Buy (N/A) |
2.02 (26.53) |
1213.37% | Details | |
| 11/15/2019 | SELLAS Life Sciences Group | SLS | Upgrade | Buy (Hold) |
6.17 (5.53) |
-10.37% | Details | |
| 11/7/2019 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2019 | Gilead Sciences | GILD | Downgrade | Hold (Buy) |
66.00 (143.93) |
118.08% | Details | |
| 10/23/2019 | Titan Pharmaceuticals | TTNP | Upgrade | Buy (Hold) |
0.19 (0.30) |
57.89% | Details | |
| 10/10/2019 | BioCardiAa | BCDA | New Coverage | Buy (N/A) |
3.36 (1.18) |
-64.88% | Details | |
| 10/10/2019 | AIM ImmunoTech | AIM | Upgrade | Buy (Hold) |
0.57 (2.44) |
328.07% | Details | |
| 9/25/2019 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2019 | Neurotrope | NTRP | Downgrade | Hold (Buy) |
4.40 (2.93) |
-33.41% | Details | |
| 9/6/2019 | Del Mar Pharma | DMPI | New Coverage | Buy (N/A) |
0.61 (1.34) |
119.67% | Details | |
| 8/22/2019 | Hemispherx | HEB | Downgrade | Hold (Buy) |
1.92 (1.80) |
-6.25% | Details | |
| 8/15/2019 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.70 (0.19) |
-72.86% | Details | |
| 8/15/2019 | Abeona Therapeutics | ABEO | Downgrade | Hold (Buy) |
2.43 (4.85) |
99.59% | Details | |
| 8/6/2019 | Hancock Jaffe Laboratories | HJLI | New Coverage | Buy (N/A) |
1.13 (10.38) |
818.58% | Details | |
| 8/2/2019 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | TrovaGene | TROV | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Immutep Limited | IMMP | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Entera Bio | ENTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2019 | Intec Pharma Ltd. | NTEC | Downgrade | Hold (Buy) |
2.99 (9.63) |
222.07% | Details | |
| 7/9/2019 | Artelo Biosciences, Inc. | ARTL | New Coverage | Buy (N/A) |
4.15 (1.14) |
-72.53% | Details | |
| 6/27/2019 | Atossa Genetics | ATOS | Downgrade | Hold (Buy) |
2.23 (1.42) |
-36.32% | Details | |
| 6/26/2019 | Titan Pharmaceuticals | TTNP | New Coverage | Buy (N/A) |
1.40 (0.70) |
-50% | Details | |
| 6/25/2019 | Cassava Sciences | SAVA | New Coverage | Buy (N/A) |
1.24 (8.11) |
554.03% | Details | |
| 6/18/2019 | bluebird bio | BLUE | Upgrade | Buy (Hold) |
117.66 (4.97) |
-95.78% | Details | |
| 6/14/2019 | Hemispherx | HEB | New Coverage | Buy (N/A) |
5.35 (1.92) |
-64.11% | Details | |
| 6/14/2019 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
2.65 (4.27) |
61.13% | Details | |
| 6/11/2019 | ContraFect Corp. | CFRX | New Coverage | Buy (N/A) |
0.42 (0.23) |
-45.24% | Details | |
| 5/3/2019 | ContraFect Corp. | CFRX | New Coverage | Buy (N/A) |
0.56 (0.42) |
-25% | Details | |
| 4/30/2019 | BeyondSpring Inc. | BYSI | Downgrade | Hold (Buy) |
15.54 (1.45) |
-90.67% | Details | |
| 4/9/2019 | Co-Diagnostics | CODX | New Coverage | Buy (N/A) |
1.07 (17.81) |
1564.49% | Details | |
| 4/3/2019 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2019 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2019 | Proteon Therapeutics | PRTO | Downgrade | Hold (Buy) |
3.48 (0.84) |
-75.86% | Details | |
| 3/27/2019 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Biocept | BIOC | New Coverage | Buy (N/A) |
1.03 (0.43) |
-58.25% | Details | |
| 3/22/2019 | SELLAS Life Sciences Group | SLS | Downgrade | Hold (Buy) |
1.31 (6.17) |
370.99% | Details | |
| 3/20/2019 | ContraVir Pharma | CTRV | Downgrade | Hold (Buy) |
0.31 (3.58) |
1054.84% | Details | |
| 3/19/2019 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2019 | INmune Bio Inc. | INMB | New Coverage | Buy (N/A) |
7.08 (1.33) |
-81.21% | Details | |
| 3/18/2019 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | Proteon Therapeutics | PRTO | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2019 | AzurRx Biopharma | AZRX | New Coverage | Buy (N/A) |
1.81 (3.45) |
90.61% | Details | |
| 2/6/2019 | Vertex | VRTX | Downgrade | Hold (Buy) |
187.02 (456.69) |
144.19% | Details | |
| 1/24/2019 | BioTime, Inc. | BTX | New Coverage | Buy (N/A) |
0.94 (6.42) |
582.98% | Details | |
| 1/3/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2018 | Capricor Therapeutics | CAPR | Downgrade | Hold (Buy) |
0.45 (1.53) |
240% | Details | |
| 12/13/2018 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2018 | Moleculin Biotech | MBRX | New Coverage | Buy (N/A) |
1.31 (2.08) |
58.78% | Details | |
| 11/12/2018 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2018 | IsoRay, Inc. | ISR | Downgrade | Hold (Buy) |
0.48 (0.38) |
-20.83% | Details | |
| 10/30/2018 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
1.95 (1.83) |
-6.15% | Details | |
| 10/30/2018 | Proteon Therapeutics | PRTO | New Coverage | Buy (N/A) |
1.60 (3.48) |
117.5% | Details | |
| 10/18/2018 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2018 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2018 | Aridis Pharmaceuticals | ARDS | New Coverage | Buy (N/A) |
13.06 (0.00) |
-100% | Details | |
| 9/25/2018 | Bionano Genomics | BNGO | New Coverage | Buy (N/A) |
6.99 (1.12) |
-83.98% | Details | |
| 9/24/2018 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2018 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2018 | IntelGenx Technologies Corp | IGXT | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2018 | Adamis Pharmaceuticals | ADMP | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Cytori Therapeutics, Inc. | CYTX | Downgrade | Hold (Buy) |
0.38 (0.21) |
-44.74% | Details |
